Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00038012 · ClinicalTrials.gov registry record · NA
rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving Carboplatin
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT00038012: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT00038012 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00038012, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
A Pilot Study of Transfusion of rhTPO-Derived Autologous Platelets Cryopreserved with ThromboSol and 2% DMSO in Patients with Gynecologic Malignancy Receiving Carboplatin
Interventions
- DRUG Carboplatin
- DRUG Thrombopoietin
- PROCEDURE Platelet-pheresis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 1999-07-23 |
| Est. Completion | 2004-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00038012
The ClinicalTrials.gov registry entry for NCT00038012 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Carboplatin is the first listed.
NCT00038012 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00038012 about?
NCT00038012 is a clinical study titled "rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving Carboplatin". A Pilot Study of Transfusion of rhTPO-Derived Autologous Platelets Cryopreserved with ThromboSol and 2% DMSO in Patients with Gynecologic Malignancy Receiving Carboplatin
What is the current status of trial NCT00038012?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 1999-07-23. Estimated completion is 2004-06.
What interventions are being tested in trial NCT00038012?
The interventions under investigation include: Carboplatin (DRUG), Thrombopoietin (DRUG), Platelet-pheresis (PROCEDURE).
Who is sponsoring clinical trial NCT00038012?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.